ArticleJournal of psychiatry & neuroscience : JPN2017

The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease.

Mari Paz Serrano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.